Perspectives on selective retroinfusion of coronary veins as an alternative approach for myocardial gene transfer and angiogenesis

Journal of Invasive Cardiology

Volumn 13, Issue 4, 2001, Pages 339-342

  Boekstegers, Peter ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CORONARY BLOOD VESSEL; GENE THERAPY; GENE TRANSFER; HEART MUSCLE ISCHEMIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION;

CORONARY VESSELS; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; INFUSIONS, INTRAVENOUS; MYOCARDIAL ISCHEMIA;

EID: 0035320671     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Boekstegers P, Peters W, Von Degenfeld G, et al. Preservation of regional myocardial function and myocardial oxygen tension during acute ischemia in pigs: Comparison of selective synchronized suction and retroinfusion of coronary veins (SSR) to synchronized coronary venous retroperfusion (SRP). J Am Coll Cardiol 1994;23:459-469.
2. Boekstegers P, von Degenfeld G, Giehrl W, Steinbeck G. Selective suction and pressure-regulated retroinfusion: An effective and safe approach to retrograde protection against myocardial ischemia in patients undergoing normal and high risk percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1998;31:1525-1533.
3. Oh BH, Volpini M, Kambayashi M, et al. Myocardial function and transmural blood flow during coronary venous retroperfusion in pigs. Circulation 1992;86:1265-1279.
4. Giehrl W, von Degenfeld G, Boekstegers P. Die druckgesteuerte selektive Retroinfusion von Koronarvenen (SSR) erlaubt die Anpassung des Retroinfusionsdruckes an das individuelle Koronarvenensystem zur Optimierung der Myokardprotektion während koronarer Ischämie (Abstr). Z Kardiol 1996;85:169.
5. Giehrl W, Von Degenfeld G, Molnar A, et al. The coronary veins as an alternative access to ischaemic myocardium: Experiences in 260 patients undergoing high risk PTCA (Abstr). Eur Heart J 2000;21:162.
6. Boekstegers P, Degenfeld G, Giehrl W, et al. Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins. Gene Therapy 2000;7:232-240.
7. Hatori N, Sjoquist PO, Regardh C, Ryden L. Pharmacokinetic analysis of coronary sinus retroinfusion in pigs. Ischemic myocardial concentrations in the left circumflex arterial area using metoprolol as a tracer. Cardiovasc Drugs Ther 1991;5:1005-1010.
8. Ryden L, et al. Pharmacokinetic analysis of coronary venous retroinfusion: A comparison with anterograde coronary artery drug administration using metoprolol as a tracer. J Am Coll Cardiol 1991;18:603-612.
9. Haga, et al. Ischemic and nonischemic tissue concentrations of felodipine after coronary venous retroinfusion during myocardial ischemia and reperfusion: An experimental study in pigs. J Cardiovasc Pharmacol 1994;24:298-302.
10. von Degenfeld G, Giehrl W, Boekstegers P. Targeting of dobutamine to ischemic myocardium without systemic effects by selective suction and pressure-regulated retroinfusion. Cardiovasc Res 1997;35:233-240.
11. Kupatt C, Habazettl H, Gödecke A, et al. TNF trägt zur erhöhten subakuten Leukozytenadhäsion in der postischämischen Reperfusion bei (Abstr). Z F Kardiol 1999;88;171.
12. von Degenfeld G, Lebherz C, Raake P, et al. Functionally relevant therapeutic angiogenesis by selective pressure-regulated retroinfusion of basic fibroblast growth factor into coronary veins in chronic myocardial ischemia in pigs (Abstr). Circulation 2000;102:II-310.
13. Kupatt Ch, Wichels R, Molnar A, et al. Regionally targeted NF(B decoy transfection by selective pressure-regulated retroinfusion improves cardiac function and diminishes infarct size 7 days after ischemia in pigs (Abstr). Circulation 2000;102:II-347.
14. Kochanek S, Clemens PR, Mitani K, et al. A new adenoviral vector: Replacement of all viral coding sequences with 28kb of DNA independently expressing both full length dystrophin and β-galactosidase. Proc Natl Acad Sci USA 1996;93:5731-5736.
15. Franz WM, Müller OJ, Katus HA, et al. Myocardial specific gene delivery. In: Hasenfuß G, Marban E (eds). Molecular approaches to heart failure. Steinhopf Verlag, Damnstraft, 2000: pp. 126-143.